“Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy” (2014) Journal of Analytical Oncology, 3(2), pp.  73–78. doi:10.6000/1927-7229.2014.03.02.1.